These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 23274669

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B.
    Li CZ, Hu JJ, Xue JY, Yin W, Liu YY, Fan WH, Xu H, Liang XS.
    World J Gastroenterol; 2014 Jul 28; 20(28):9486-96. PubMed ID: 25071343
    [Abstract] [Full Text] [Related]

  • 3. Functional restoration of CD56bright NK cells facilitates immune control via IL-15 and NKG2D in patients under antiviral treatment for chronic hepatitis B.
    Chen T, Zhu L, Shi A, Ding L, Zhang X, Tan Z, Guo W, Yan W, Han M, Jia J, Luo X, Schuppan D, Ning Q.
    Hepatol Int; 2017 Sep 28; 11(5):419-428. PubMed ID: 28639033
    [Abstract] [Full Text] [Related]

  • 4. Effects of entecavir on peripheral blood lymphocyte profiles in chronic hepatitis B patients with suboptimal responses to adefovir.
    Zhang L, Wang Q, Zhao P, Hu X, Jiang Y.
    Clin Exp Pharmacol Physiol; 2014 Jul 28; 41(7):514-23. PubMed ID: 24773272
    [Abstract] [Full Text] [Related]

  • 5. Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment.
    Li C, Ji H, Cai Y, Ayana DA, Lv P, Liu M, Jiang Y.
    J Interferon Cytokine Res; 2013 Oct 28; 33(10):612-8. PubMed ID: 23697556
    [Abstract] [Full Text] [Related]

  • 6. Recovery of circulating CD56dim NK cells and the balance of Th17/Treg after nucleoside analog therapy in patients with chronic hepatitis B and low levels of HBsAg.
    Liu N, Liu B, Zhang L, Li H, Chen Z, Luo A, Chen M, Peng M, Yin W, Ren H, Hu P.
    Int Immunopharmacol; 2018 Sep 28; 62():59-66. PubMed ID: 29990695
    [Abstract] [Full Text] [Related]

  • 7. TCRγδ(+)CD4(-)CD8(-) T cells suppress the CD8(+) T-cell response to hepatitis B virus peptides, and are associated with viral control in chronic hepatitis B.
    Lai Q, Ma S, Ge J, Huang Z, Huang X, Jiang X, Li Y, Zhang M, Zhang X, Sun J, Abbott WG, Hou J.
    PLoS One; 2014 Sep 28; 9(2):e88475. PubMed ID: 24551107
    [Abstract] [Full Text] [Related]

  • 8. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.
    Chen Y, Li X, Ye B, Yang X, Wu W, Chen B, Pan X, Cao H, Li L.
    Antiviral Res; 2011 Jul 28; 91(1):23-31. PubMed ID: 21549152
    [Abstract] [Full Text] [Related]

  • 9. Dynamic analysis of CD127 expression on memory CD8 T cells from patients with chronic hepatitis B during telbivudine treatment.
    Lv G, Ying L, Ma WJ, Jin X, Zheng L, Li L, Yang Y.
    Virol J; 2010 Aug 31; 7():207. PubMed ID: 20807412
    [Abstract] [Full Text] [Related]

  • 10. Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment: A longitudinal observational study.
    Yang X, Li J, Liu J, Gao M, Zhou L, Lu W.
    Medicine (Baltimore); 2017 Jun 31; 96(23):e7064. PubMed ID: 28591041
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir.
    Park H, Park JY, Kim SU, Kim DY, Han KH, Chon CY, Ahn SH.
    World J Gastroenterol; 2013 Jun 31; 19(43):7671-9. PubMed ID: 24431895
    [Abstract] [Full Text] [Related]

  • 12. Telbivudine therapy may shape CD4(+) T-cell response to prevent liver fibrosis in patients with chronic hepatitis B.
    Li J, Jia M, Liu Y, She W, Li L, Wang J, Jiang W.
    Liver Int; 2015 Mar 31; 35(3):834-45. PubMed ID: 24814578
    [Abstract] [Full Text] [Related]

  • 13. Telbivudine decreases proportion of peripheral blood CD4+CD25+CD127low T cells in parallel with inhibiting hepatitis B virus DNA.
    Yan Z, Zhou J, Zhang M, Fu X, Wu Y, Wang Y.
    Mol Med Rep; 2014 May 31; 9(5):2024-30. PubMed ID: 24626572
    [Abstract] [Full Text] [Related]

  • 14. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
    Li M, Sun X, Zhou Z, Zhang X, Jin S, Gao Y, Gao Y.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb 31; 32(2):240-4. PubMed ID: 26927386
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of telbivudine treatment for hepatitis B e antigen-positive chronic hepatitis B patients with poor response to adefovir dipivoxil.
    Li Y, Zhang Y, Wang JP, Lian JQ, Bai XF.
    J Viral Hepat; 2013 Apr 31; 20 Suppl 1():46-51. PubMed ID: 23458524
    [Abstract] [Full Text] [Related]

  • 16. Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir.
    Zhao PW, Jia FY, Shan YX, Ji HF, Feng JY, Niu JQ, Ayana DA, Jiang YF.
    Clin Exp Pharmacol Physiol; 2013 Mar 31; 40(3):190-6. PubMed ID: 23278368
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of 104-week Telbivudine-based optimization strategy in patients with HBeAg-negative chronic hepatitis B virus infections.
    Gan W, Li J, Zhang C, Chen X, Lin C, Gao Z.
    BMC Infect Dis; 2020 Dec 07; 20(1):931. PubMed ID: 33287722
    [Abstract] [Full Text] [Related]

  • 18. A randomized controlled trial of sequential pegylated interferon-α and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B.
    Piccolo P, Lenci I, di Paolo D, Demelia L, Sorbello O, Nosotti L, Angelico M.
    Antivir Ther; 2013 Dec 07; 18(1):57-64. PubMed ID: 22872648
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of telbivudine in HBeAg-positive chronic hepatitis B patients with high baseline ALT levels.
    Lv GC, Ma WJ, Ying LJ, Jin X, Zheng L, Yang YD.
    World J Gastroenterol; 2010 Aug 28; 16(32):4095-9. PubMed ID: 20731026
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of telbivudine antiviral treatment in patients with hepatitis B virus-associated glomerulonephritis: A 104-week pilot study.
    Yan Z, Qiao B, Zhang H, Wang Y, Gou W.
    Medicine (Baltimore); 2018 Aug 28; 97(31):e11716. PubMed ID: 30075577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.